4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-23-002114
COO and General Counsel sold 17,500 shares at an average $38.33 ($670,802)
- COO and General Counsel acquired 65,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
O'Brien Patrick · COO and General Counsel
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-03 | Sale : show line 1 in the form | −2,653 | $37.53 | $99,567 | 378,222 | D |
| 2023-01-03 | Sale : show line 2 in the form | −5,527 | $38.54 | $213,011 | 372,695 | D |
| 2023-01-03 | Sale : show line 3 in the form | −500 | $39.74 | $19,870 | 372,195 | D |
| 2023-01-03 | Sale : show line 4 in the form | −70 | $40.80 | $2,856 | 372,125 | D |
| 2023-01-03 | Sale : show line 5 in the form | −2,894 | $37.58 | $108,757 | 369,231 | D |
| 2023-01-03 | Sale : show line 6 in the form | −5,286 | $38.58 | $203,934 | 363,945 | D |
| 2023-01-03 | Sale : show line 7 in the form | −300 | $39.55 | $11,865 | 363,645 | D |
| 2023-01-03 | Sale : show line 8 in the form | −270 | $40.53 | $10,943 | 363,375 | D |
| 2023-01-04 | Grant or award : show line 9 in the form | +65,000 | 428,375 | D | ||
| Open-market sales · 17,500 sh · avg $38.33 · $670,802 | ||||||
Loading xslF345X03/doc4.xml…